New Business Models Needed As Production Plateaus In China: PharmAsia Summit
This article was originally published in PharmAsia News
Executive Summary
Big Pharma executives expect China will continue to grow in importance for their companies, and about 40% said China will be one of the top three markets for the majority of companies, according to a new report unveiled at the PharmAsia Summit Shanghai.